A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors

NCT03595059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABBV-155
DRUG: Paclitaxel
DRUG: Docetaxel

Sponsor

AbbVie